-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Costs and Expenses history and growth rate from Q2 2018 to Q2 2024.
- Heron Therapeutics, Inc. /De/ Costs and Expenses for the quarter ending June 30, 2024 was $32M, a 40.8% decline year-over-year.
- Heron Therapeutics, Inc. /De/ Costs and Expenses for the twelve months ending June 30, 2024 was $136M, a 17.1% decline year-over-year.
- Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2023 was $173M, a 24.1% decline from 2022.
- Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2022 was $227M, a 25.2% decline from 2021.
- Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2021 was $304M, a 3.99% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)